Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges
Few guidelines exist for COVID-19 vaccination amongst cancer patients, fostering uncertainty regarding the immunogenicity, safety, and effects of cancer therapies on vaccination, which this review aims to address. A literature review was conducted to include the latest articles covering the immunoge...
Main Authors: | Muna Almasri, Khalifa Bshesh, Wafa Khan, Malik Mushannen, Mohammad A. Salameh, Ameena Shafiq, Ahamed Lazim Vattoth, Nadine Elkassas, Dalia Zakaria |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/22/5630 |
Similar Items
-
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
by: James T. Peterson, et al.
Published: (2019-03-01) -
Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine:a phase I clinical trial
by: Zhi-Wei Wu, et al.
Published: (2021-07-01) -
Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study
by: Kei Nakashima, et al.
Published: (2022-11-01) -
Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial
by: Zhi-Wei Wu, et al.
Published: (2023-08-01) -
Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
by: Xiaoyuan Huang, et al.
Published: (2023-01-01)